Literature DB >> 22156867

Factors associated with oncologic outcomes after abdominoperineal resection compared with restorative resection for low rectal cancer: patient- and tumor-related or technical factors only?

Avraham Reshef1, Ian Lavery, Ravi P Kiran.   

Abstract

BACKGROUND: Previous reports suggest that patients with rectal cancer undergoing abdominoperineal resection have worse oncologic outcomes in comparison with those undergoing restorative rectal resection.
OBJECTIVE: This study aimed to assess factors influencing oncologic outcomes for patients undergoing surgery for rectal cancer.
DESIGN: This study is a retrospective review of prospectively gathered data.
SETTING: Data were gathered from a prospective cancer database. PATIENTS: Patients were included who underwent radical resection for mid and lower third rectal cancer (1991-2006). MAIN OUTCOME MEASURES: The primary outcomes measured were the impact of various factors on perioperative outcomes, local recurrence, and disease-free survival for patients undergoing abdominoperineal resection.
RESULTS: Four hundred thirteen (29%) patients underwent abdominoperineal resection and 993 (71%) underwent restorative resection for rectal cancer. Patients with abdominoperineal resection were older (p < 0.0001), had a higher mean ASA score (p < 0.001), worse tumor differentiation (p < 0.001), and higher tumor stage (p = 0.0001). Although overall morbidity was lower in the abdominoperineal resection group (p = 0.001), the length of stay was greater (p < 0.001). After a similar period of follow-up (5.2 ± 3.9 vs 5.3 ± 3.4 y, p = 0.58), local recurrence (7% vs 3%, p = 0.02) was higher after abdominoperineal resection, but overall survival (56% vs 71%, p < 0.001) and disease-free survival (54% vs 70%, p < 0.001) were lower. On multivariate analysis, higher stage, poor tumor differentiation, involved margins, and older age were associated with worse survival, whereas higher stage, poor tumor differentiation, and abdominoperineal resection were associated with greater recurrence. These worse oncologic outcomes persisted even when the groups were stratified based on the location of the cancer in mid or distal rectum and for patients with a clear circumferential margin. LIMITATION: This study was limited by its retrospective nature.
CONCLUSION: Technical factors alone are unlikely to be responsible for the worse outcomes after abdominoperineal resection in comparison with restorative resection. A combination of patient- and tumor-related factors that may have indicated the choice of the procedure also probably contribute to the worse outcomes. Because patients undergoing abdominoperineal resection represent a high risk for poor outcomes, management strategies need to consider all these factors during treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22156867     DOI: 10.1097/DCR.0b013e3182351c1f

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  17 in total

1.  Are we denying distant control? A call for revising the treatment protocols of patients with ultra-low rectal cancer who potentially require abdominoperineal resection.

Authors:  Bilal Baker; Abdel-Munem Abu Sba
Journal:  J Gastrointest Cancer       Date:  2014-06

2.  [Factors influencing circumferential resection margins and the oncological results after abdominoperineal rectal excision : results of a multicentre study].

Authors:  J Reibetanz; C-T Germer
Journal:  Chirurg       Date:  2013-05       Impact factor: 0.955

3.  A novel risk-adjusted nomogram for rectal cancer surgery outcomes.

Authors:  Maria C Russell; Y Nancy You; Chung-Yuan Hu; Janice N Cormier; Barry W Feig; John M Skibber; Miguel A Rodriguez-Bigas; Heidi Nelson; George J Chang
Journal:  JAMA Surg       Date:  2013-08       Impact factor: 14.766

4.  A comparison of the technical and oncologic validity between robot-assisted and conventional open abdominoperineal resection.

Authors:  Jin C Kim; Jae Y Kwak; Yong S Yoon; In J Park; Chan W Kim
Journal:  Int J Colorectal Dis       Date:  2014-06-10       Impact factor: 2.571

5.  Laparoscopic vs open abdominoperineal resection in the multimodality management of low rectal cancers.

Authors:  Yu-Wei Wang; Li-Yong Huang; Cheng-Li Song; Chang-Hua Zhuo; De-Bing Shi; Guo-Xiang Cai; Ye Xu; San-Jun Cai; Xin-Xiang Li
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

Review 6.  Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer.

Authors:  Jin-ichi Hida; Kiyotaka Okuno; Tadao Tokoro
Journal:  Surg Today       Date:  2013-12-22       Impact factor: 2.549

7.  Abdominoperineal excision following preoperative radiotherapy for rectal cancer: unfavorable prognosis even with negative circumferential resection margin.

Authors:  Lin Wang; Guo-Li Gu; Zhong-Wu Li; Yi-Fan Peng; Jin Gu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 8.  Conversations for providers caring for patients with rectal cancer: Comparison of long-term patient-centered outcomes for patients with low rectal cancer facing ostomy or sphincter-sparing surgery.

Authors:  Lisa J Herrinton; Andrea Altschuler; Carmit K McMullen; Joanna E Bulkley; Mark C Hornbrook; Virginia Sun; Christopher S Wendel; Marcia Grant; Carol M Baldwin; Wendy Demark-Wahnefried; Larissa K F Temple; Robert S Krouse
Journal:  CA Cancer J Clin       Date:  2016-03-21       Impact factor: 508.702

9.  Systematic review of oncological outcomes following laparoscopic vs open total mesorectal excision.

Authors:  Muhammad Shafique Sajid; Adil Ahamd; William Fa Miles; Mirza Khurrum Baig
Journal:  World J Gastrointest Endosc       Date:  2014-05-16

10.  Anastomotic leakage after curative rectal cancer resection has no impact on long-term survival: a propensity score analysis.

Authors:  Sabrina M Ebinger; René Warschkow; Ignazio Tarantino; Bruno M Schmied; Lukas Marti
Journal:  Int J Colorectal Dis       Date:  2015-08-06       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.